Merck & Company Inc (new)

MRK 
(NYSE) 
 
$ 82.78 <%= Resources.Global.txtUp %>
Updated 13/06/2019
Change % 0.52% Stock price increasing
Change 0.43 Stock price increasing
Volume 2,891,079
High $ 83.37
Low $ 82.46
Open $ 82.59
ISIN
Prev close $ 82.35
# of shares 2,574.64M
Market cap 213,129M USD
Intraday

Market closed
Merck & Company Inc (ne
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  82.78 0.4% Stock price increasing 4.6% Stock price increasing 1.5% Stock price increasing 8.2% Stock price increasing 33.5% Stock price increasing
Powered by TradingView

News about Merck & Company Inc (ne

  • English
  • Regulatory news

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Abbott Laboratories 82.22 1.8% Stock price increasing 7.3% Stock price increasing 3.0% Stock price increasing 16.2% Stock price increasing 30.7% Stock price increasing 13.7% Stock price increasing
 
Baxter International Inc 77.93 0.5% Stock price increasing 1.3% Stock price increasing 1.3% Stock price increasing 18.6% Stock price increasing 3.6% Stock price increasing 18.4% Stock price increasing
 
Bristol-Myers Squibb Company 47.56 1.7% Stock price increasing 0.9% Stock price increasing -4.8% Stock price decreasing -8.7% Stock price decreasing -13.2% Stock price decreasing -8.5% Stock price decreasing
 
Johnson & Johnson 140.09 1.1% Stock price increasing 1.4% Stock price increasing 1.8% Stock price increasing 5.3% Stock price increasing 14.3% Stock price increasing 8.6% Stock price increasing
 
Eli Lilly and Company 111.74 -5.6% Stock price decreasing -4.3% Stock price decreasing -9.8% Stock price decreasing -0.2% Stock price decreasing 28.6% Stock price increasing -3.4% Stock price decreasing
 
Pfizer Inc 42.76 -0.4% Stock price decreasing 2.7% Stock price increasing 2.3% Stock price increasing -2.4% Stock price decreasing 17.6% Stock price increasing -2.0% Stock price decreasing
 
Gilead Sciences Inc 66.36 1.5% Stock price increasing 0.9% Stock price increasing 1.1% Stock price increasing 1.2% Stock price increasing -5.5% Stock price decreasing 6.1% Stock price increasing
 
Astrazeneca PLC ORD SHS $0.25 6,215.00 3.1% Stock price increasing 5.7% Stock price increasing -0.9% Stock price decreasing 1.4% Stock price increasing 15.1% Stock price increasing 5.8% Stock price increasing
 
Merck Kgaa O.N. 91.80 2.6% Stock price increasing 0.2% Stock price increasing -6.7% Stock price decreasing -4.9% Stock price decreasing 8.8% Stock price increasing 2.0% Stock price increasing
 
Novartis NAM SF 0,50 79.74 2.1% Stock price increasing 7.5% Stock price increasing -3.3% Stock price decreasing 2.8% Stock price increasing 22.1% Stock price increasing 7.2% Stock price increasing
 
Roche Hldg AG GEN 246.95 2.1% Stock price increasing 5.7% Stock price increasing 3.0% Stock price increasing 11.5% Stock price increasing 37.3% Stock price increasing 14.6% Stock price increasing
 
Glaxosmithkline PLC ORD 25P 1,584.40 1.2% Stock price increasing 2.2% Stock price increasing 5.5% Stock price increasing 7.1% Stock price increasing 1.8% Stock price increasing 6.3% Stock price increasing
 
Sanofi 75.98 -3.0% Stock price decreasing 1.3% Stock price increasing -4.5% Stock price decreasing -2.9% Stock price decreasing 10.6% Stock price increasing 0.4% Stock price increasing
 
Bayer AG NA O.N. 52.85 0.0% Stock price decreasing -7.8% Stock price decreasing -22.0% Stock price decreasing -16.6% Stock price decreasing -47.2% Stock price decreasing -12.7% Stock price decreasing
 
Teva Pharmaceutical Industries.. 8.240 -11.0% Stock price decreasing -27.8% Stock price decreasing -50.1% Stock price decreasing -55.4% Stock price decreasing -65.3% Stock price decreasing -46.6% Stock price decreasing

Company profile

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiovascular disease, asthma, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the company's sales are generated in the United States.

Peers

Instruments Last Change  
Abbott Labor.. 82.22 -0.1% Stock price decreasing
Baxter Inter.. 77.93 -0.4% Stock price decreasing
Bristol-Myer.. 47.56 0.5% Stock price increasing
Johnson & Jo.. 140.09 -0.4% Stock price decreasing
Eli Lilly an.. 111.74 -0.1% Stock price decreasing
Pfizer Inc 42.76 0.6% Stock price increasing
Gilead Scien.. 66.36 -0.9% Stock price decreasing
Astrazeneca .. 6,215.00 0.3% Stock price increasing
Merck Kgaa O.. 91.80 0.1% Stock price increasing
Novartis NAM.. 79.74 0.6% Stock price increasing
Roche Hldg A.. 246.95 0.1% Stock price increasing
Glaxosmithkl.. 1,584.40 0.1% Stock price increasing
Sanofi 75.98 0.0% Stock price unchanged
Bayer AG NA .. 52.85 -1.5% Stock price decreasing
Teva Pharmac.. 8.240 -4.3% Stock price decreasing

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
16 June 2019 18:39:22
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB6 - 2019-06-16 19:39:22 - 2019-06-16 18:39:22 - 1000 - Website: OKAY